Dr. Leisha Daly:

The nine countries are part of the agreement we currently have. They were part of the negotiations conducted in 2012 when we agreed to the significant savings we have contributed over the past three years. Those negotiations dealt with how we would get new medicines onto the market and the process involved in the health technology assessments.